We examined the characteristics of mitogens extracted from human benign prostatic hyperplasia and prostatic adenocarcinoma tissue. Although mitogens for fetal rat skin fibroblasts as well as for rat calvarial osteoblasts and osterosarcoma cells were found, distinct entities that acted selectively in cells of the osteoblast phenotype could be obtained by sequential reverse-phase high performance liquid chromatography. Two peptides with apparent molecular weights of 10,000 and 13,000 D were derived from hyperplastic tissue, whereas a single moiety of 10,000 D was obtained from malignant tissue. These entities increased cell numbers and alkaline phosphatase activity in osteoblastlike cells consistent with effects on both growth and differentiation. Prostatic peptides did not stimulate adenylate cyclase in osteosarcoma cells. Mitogenic activity selective for osteoblastlike cells was identified in postpubertal but not prepubertal normal prostate. The results demonstrate the existence of osteoblastic growth factors in prostatic tissue whose presence may accompany postpubertal development.
M Koutsilieris, S A Rabbani, H P Bennett, D Goltzman
Title and authors | Publication | Year |
---|---|---|
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He Y, Xu W, Xiao YT, Huang H, Gu D, Ren S |
Signal Transduction and Targeted Therapy | 2022 |
Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy
Q Fu, Z Yu |
Life Sciences | 2020 |
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
N Mahmood, C Mihalcioiu, SA Rabbani |
Frontiers in Oncology | 2018 |
Young patient with arterial thrombosis and skin changes as the onset manifestations: POEMS syndrome
T Han, S Zheng, Z Chen, W Liu, Y Hu |
Oncotarget | 2016 |
Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer
A Armakolas, M Kaparelou, A Dimakakos, E Papageorgiou, N Armakolas, A Antonopoulos, C Petraki, M Lekarakou, P Lelovas, M Stathaki, C Psarros, I Donta, PS Galanos, P Msaouel, VG Gorgoulis, M Koutsilieris |
Molecular Medicine | 2015 |
Prospective Comparison of 99m Tc-MDP Scintigraphy, Combined 18 F-NaF and 18 F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer
R Minamimoto, A Loening, M Jamali, A Barkhodari, C Mosci, T Jackson, P Obara, V Taviani, SS Gambhir, S Vasanawala, A Iagaru |
Journal of Nuclear Medicine | 2015 |
Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer
P Msaouel, G Nandikolla, SG Pneumaticos, M Koutsilieris |
Expert Opinion on Investigational Drugs | 2013 |
Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer
A Philippou, A Armakolas, M Koutsilieris |
Frontiers in Endocrinology | 2013 |
Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications
SG Pneumaticos, A Christofides, E Gkioka, T Kalogeropoulos, P Msaouel, M Koutsilieris |
Expert Opinion on Therapeutic Targets | 2013 |
Expression of IGF-1Ec (MGF) transcript in human prostate cancer: evidence for a novel and autonomous growth factor activity of MGF E peptide in human PC-3 and LNCaP prostate cancer cells
Athanasios Armakolas, Anastassioss Philippou, Zacharoula Panteleakou, Adrew Nezos, Antigoni Sourla, Constantine Petraki, Michael Koutsilieris |
The Prostate | 2010 |
Expression of PGK1 by Prostate Cancer Cells Induces Bone Formation
Y Jung, Y Shiozawa, J Wang, J Wang, Z Wang, EA Pedersen, CH Lee, CL Hall, PJ Hogg, PH Krebsbach, ET Keller, RS Taichman |
Molecular cancer research : MCR | 2009 |
IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro
A Stavropoulou, A Halapas, A Sourla, A Philippou, E Papageorgiou, A Papalois, M Koutsilieris |
Molecular Medicine | 2009 |
Bone Metastases
D Kardamakis, V Vassiliou, E Chow |
2009 | |
Mechanisms of bone metastasis in prostate cancer: clinical implications
P Msaouel, N Pissimissis, A Halapas, M Koutsilieris |
Best Practice & Research Clinical Endocrinology & Metabolism | 2008 |
Orthopaedic bone cements
M Phillips, K Joshi |
Orthopaedic bone cements | 2008 |
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells
E Papageorgiou, N Pitulis, M Manoussakis, P Lembessis, M Koutsilieris |
Molecular Medicine | 2008 |
The kisspeptin (KiSS-1)/GPR54 system in cancer biology
A Makri, N Pissimissis, P Lembessis, C Polychronakos, M Koutsilieris |
Cancer Treatment Reviews | 2008 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
Characterization of Osteolytic, Osteoblastic, and Mixed Lesions in a Prostate Cancer Mouse Model Using 18 F-FDG and 18 F-Fluoride PET/CT
WK Hsu, MS Virk, BT Feeley, DB Stout, AF Chatziioannou, JR Lieberman |
Journal of Nuclear Medicine | 2008 |
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach
M Koutsilieris, J Bogdanos, C Milathianakis, P Dimopoulos, T Dimopoulos, D Karamanolakis, A Halapas, R Tenta, H Katopodis, E Papageorgiou, N Pitulis, N Pissimissis, P Lembessis, A Sourla |
Expert Opinion on Investigational Drugs | 2006 |
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions
BT Feeley, L Krenek, N Liu, WK Hsu, SC Gamradt, EM Schwarz, J Huard, JR Lieberman |
Bone | 2006 |
Influence of BMPs on the Formation of Osteoblastic Lesions in Metastatic Prostate Cancer
BT Feeley, SC Gamradt, WK Hsu, N Liu, L Krenek, P Robbins, J Huard, JR Lieberman |
Journal of Bone and Mineral Research | 2005 |
Integration/Interaction of Oncologic Growth
GG Meadows |
2005 | |
The Biology of Skeletal Metastases
ET Keller, LW Chung |
2004 | |
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone
Y Lee, E Schwarz, M Davies, M Jo, J Gates, J Wu, X Zhang, JR Lieberman |
Journal of Orthopaedic Research | 2003 |
A Proteome Study of Secreted Prostatic Factors Affecting Osteoblastic Activity: Galectin-1 Is Involved in Differentiation of Human Bone Marrow Stromal Cells
H Andersen, ON Jensen, EP Moiseeva, EF Eriksen |
Journal of Bone and Mineral Research | 2003 |
A proteome study of secreted prostatic factors affecting osteoblastic activity: identification and characterisation of cyclophilin A
H Andersen, ON Jensen, EF Eriksen |
European Journal of Cancer | 2003 |
Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer
H Masuda, Y Fukabori, K Nakano, Y Takezawa, T cSuzuki, H Yamanaka |
The Prostate | 2003 |
Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer
M Koutsilieris, CS Mitsiades |
Expert Opinion on Investigational Drugs | 2001 |
Antalgic treatment of pain associated with bone metastases
C Reale, AM Turkiewicz, CA Reale |
Critical Reviews in Oncology/Hematology | 2001 |
ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line
N Juretic, JF Santib��ez, C Hurtado, J Mart�nez |
Journal of Cellular Biochemistry | 2001 |
Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption
JW Chiao, BS Moonga, YM Yang, R Kancherla, A Mittelman, JR Wu-Wong, T Ahmed |
British Journal of Cancer | 2000 |
Insulin-like Growth Factor I and Urokinase-type Plasminogen Activator Bioregulation System as a Survival Mechanism of Prostate Cancer Cells in Osteoblastic Metastases: Development of Anti-Survival Factor Therapy for Hormone-Refractory Prostate Cancer
M Koutsilieris, C Mitsiades, A Sourla |
Molecular Medicine | 2000 |
Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein
EA Blomme, KM Dougherty, KJ Pienta, CC Capen, TJ Rosol, LK McCauley |
The Prostate | 1999 |
Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: Case report
M Koutsilieris, M Tzanela, T Dimopoulos |
The Prostate | 1999 |
Thy-1 Antigen Expression by Cells in the Osteoblast Lineage
XD Chen, HY Qian, L Neff, K Satomura, MC Horowitz |
Journal of Bone and Mineral Research | 1999 |
The biology and management of bone metastases
TA Plunkett, RD Rubens |
Critical Reviews in Oncology/Hematology | 1999 |
Detection of an inhibiting activity for osteoclast bone resorption from human prostatic cancer cells
BS Moonga, JW Chiao |
Cancer Letters | 1998 |
Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis
C Reyes-Moreno, A Sourla, I Choki, C Doillon, M Koutsilieris |
Urology | 1998 |
Cancer and Bone*
TA Guise, GR Mundy |
Endocrine reviews | 1998 |
Osteoporosis
DL Glaser, FS Kaplan |
Spine | 1997 |
Bisphosphonates in prostate carcinoma
S Adami |
Cancer | 1997 |
Multiple myeloma associated with diffuse osteosclerotic bone lesions: A clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)
MQ Lacy, MA Gertz, CA Hanson, DJ Inwards, RA Kyle |
American Journal of Hematology | 1997 |
Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro
J Kido, N Yamauchi, K Ohishi, M Kataoka, S Nishikawa, T Nakamura, H Kadono, D Ikedo, A Ueno, N Nonomura, A Okuyama, T Nagata |
Journal of Cellular Biochemistry | 1997 |
Malignant bone pain: pathophysiology and treatment
S Mercadante |
PAIN | 1997 |
Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton
C Reyes-Moreno, M Koutsilieris |
Clinical & Experimental Metastasis | 1997 |
Prostate-derived soluble factors block osteoblast differentiation in culture
J Martínez, S Silva, JF Santibáñez |
Journal of Cellular Biochemistry | 1996 |
Soluble factors produced by PC-3 prostate cells decrease collagen content and mineralisation rate in fetal rat osteoblasts in culture
JF Santibáñez, S Silva, J Martínez |
British Journal of Cancer | 1996 |
Tumor Biology
AS Tsiftsoglou, AC Sartorelli, DE Housman, TM Dexter |
Tumor Biology | 1996 |
Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts
A Sourla, M Koutsilieris |
Journal of Clinical Investigation | 1995 |
Skeletal metastases in advanced prostate cancer: cell biology and therapy
M Koutsilieris |
Critical Reviews in Oncology/Hematology | 1995 |
Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer
M Koutsilieris, A Sourla, G Pelletier, CJ Doillon |
Journal of Bone and Mineral Research | 1994 |
Prostate cancer progression. Implications of histopathology
JL Ware |
The American Journal of Pathology | 1994 |
Biochemical and Molecular Aspects of Selected Cancers
E Eigenbrodt, U Gerbracht, S Mazurek, P Presek, R Friis |
Biochemical and Molecular Aspects of Selected Cancers | 1994 |
Case Report: Clinical Hypocalcemia: The Endocrine Conference of the Alton Ochsner Medical Institutions and Tulane University-Medical Center
MC Wiegand, A Burshell, J Jaspan, AO Odugbesan |
The American Journal of the Medical Sciences | 1994 |
Membrane Physiopathology
G Bkaily |
1994 | |
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert |
1994 | |
Ultrastructure of the Male Urogenital Glands
A Riva, FT Riva, P Motta |
1994 | |
Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells
E Canalis, M Centrella, T McCarthy |
Journal of Clinical Investigation | 1993 |
Osteoclast inhibition for the treatment of bone metastases
RE Coleman, OP Purohit |
Cancer Treatment Reviews | 1993 |
The Effects of Orchidectomy on Skeletal Metabolism in Metastatic Prostate Cancer
NW Clarke, J McClure, NJ George |
Scandinavian Journal of Urology and Nephrology | 1993 |
Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells
E Canalis, M Centrella, T McCarthy |
Journal of Clinical Investigation | 1993 |
Histology of Ancient Human Bone: Methods and Diagnosis
G Grupe, AN Garland |
1993 | |
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
JL Ware |
Cancer and Metastasis Reviews | 1993 |
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin |
1993 | |
Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
H Bentley, FC Hamdy, KA Hart, JM Seid, JL Williams, D Johnstone, RG Russell |
British Journal of Cancer | 1992 |
Urokinase and the mechanism of osteoblastic metastases by prostate cancer
D Goltzman, I Bolivar, LA Moroz, SA Rabbani |
Fibrinolysis | 1992 |
Prostate Cancer and Bone Metastasis
JP Karr, H Yamanaka |
1992 | |
Control of Growth Factors and Prevention of Cancer
MB Sporn |
1992 | |
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase
SA Rabbani, AP Mazar, SM Bernier, M Haq, I Bolivar, J Henkin, D Goltzman |
The Journal of biological chemistry | 1992 |
Mechanisms of osteolytic bone destruction
GR Mundy |
Bone | 1991 |
Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: Characterization of the receptors involved
C Polychronakos, U Janthly, JG Lehoux, M Koutsilieris |
The Prostate | 1991 |
Serum and prostatic growth-promoting factors for steroid-independent epithelial cells of adult dog prostate
S Chevalier, G McKercher, A Chapdelaine |
The Prostate | 1991 |
Growth factors in the human prostate
G Fiorelli, AD Bellis, A Longo, P Pioli, A Constantini, S Giannini, G Forti, M Serio |
The Journal of Steroid Biochemistry and Molecular Biology | 1991 |
International Review of Cytology
RA Miller |
International Review of Cytology | 1991 |
Molecular and Cellular Biology of Prostate Cancer
JP Karr, DS Coffey, RG Smith, DJ Tindall |
1991 | |
Establishment of an osseous cell line from fetal rat calvaria using an immunocytolytic method of cell selection: Characterization of the cell line and of derived clones
SM Bernier, J Desjardins, AK Sullivan, D Goltzman |
Journal of Cellular Physiology | 1990 |
Production and significance of TGF-β in AT-3 metastatic cell line established from the Dunning rat prostatic adenocarcinoma
Y Matuo, N Nishi, H Takasuka, Y Masuda, K Nishikawa, JT Isaacs, PS Adams, WL McKeehan, GH Sato |
Biochemical and Biophysical Research Communications | 1990 |
Hypocalcemia in cancer
EC Abramson, H Gajardo, SC Kukreja |
Bone and Mineral | 1990 |
Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis
M Hüfner, H Döhner, J Schmidt, P Möller, AD Ho, W Hunstein |
Klinische Wochenschrift | 1989 |
Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate
P Davies, CL Eaton |
The Prostate | 1989 |
Human uterus-derived growth substances for rat bone cells and fibroblasts
M Koutsilieris |
American Journal of Obstetrics and Gynecology | 1989 |
Hypercalcaemia of malignancy
PJ Kelly, JA Eisman |
Cancer and Metastasis Reviews | 1989 |
Hypocalcemia in patients with prostate cancer
SC Kukreja, A Shanmugam, TE Lad |
Calcified Tissue International | 1988 |
Application of octadecylsilyl-silica in purification studies related to the nontransformed rat ventral prostate androgen receptor
M Koutsilieris, F Bouthillier, F Grondin, F Radwan, M Carmel, M Elhilali, JG Lehoux |
The Prostate | 1988 |